Serotonin S2and thromboxane A2-prostaglandin H2receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries

This publication has 25 references indexed in Scilit:

• Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium.
  Journal of Clinical Investigation, 1987
• Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.
  Journal of Clinical Investigation, 1986
• Receptor specificity of the 5HT2 receptor antagonist, LY53857
  Drug Development Research, 1985
• Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms
  The American Journal of Cardiology, 1984
• Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
  Circulation, 1984
• Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?
  Circulation, 1982
• Epinephrine potentiation of arachidonate‐induced aggregation of cyclooxygenase‐deficient platelets
  American Journal of Hematology, 1981
• The influence of epinephrine on prostacyclin (PGI2) induced dissociation of adp aggregated platelets
  Prostaglandins and Medicine, 1980
• Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.
  Heart, 1979
• Platelet aggregation in partially obstructed vessels and its elimination with aspirin.
  Circulation, 1976